Chengdu FenDi Pharmaceutical Co., Ltd.
Chengdu FenDi Pharmaceutical Co., Ltd.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1 Study of FD-001 in Recurrent /Refractory (R/R)AML/NHL/MM/MDS | acute myeloid leukemia, non-Hodgkin lymphoma | Recruiting | Phase 1 | 2024-12-17 | NCT06731699 |